Department of OB-GYN, Faculty of Medicine, Chiang Mai University
Chiang Mai, 50200, Thailand
NCT Number: NCT01505920
Loop Electrosurgical Excision Procedure (LEEP) is a widely used minor surgical procedure for diagnosis and treatment of cervical intraepithelial neoplasia. During the procedure, several methods have been proposed to reducing pain including submucosal block, paracervical block, and oral analgesics. Submucosal (underneath the lining of the cervix) injection of lidocaine appeared to be the most common methods used. However, from the investigators experience, there is significant pain associated with the injection itself.
Lidocaine spray is an effective measure for pain control during minor gastrointestinal and otolaryngological procedures. It is simple without pain related to application.
An objective of this study is to examine effectiveness of lidocaine spray versus lidocaine submucosal injection by comparing pain scores at various stages of the LEEP procedure.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Phase 3
Chiang Mai, 50200, Thailand
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
10% lidocaine spray 40 mg applied directly to the cervix, 3 minutes before starting cervical excision
2% lidocaine with 1:100,000 adrenaline 2 ml injected submucosally into the four quadrant of the cervix, 3 minutes before starting cervical excision
Time frame: Immediately after the excision
Time frame: At the time of anesthetic application
Time frame: At 30 minutes after the procedure
Chiang Mai University
Other
Lidocaine Spray Compared With Submucosal Injection in Reducing Pain During Loop Electrosurgical Excision Procedure: a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01639820
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Bron, France
View Trial DetailsNCT03763565
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Bangkok, Thailand
View Trial DetailsNCT04415840
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Dortmund, North Rhine-Westphalia, Germany
View Trial DetailsNCT04326049
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Herne, North Rhine-Westphalia, Germany
View Trial Details